Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 60.60
-0.20 (-0.33%)
Aug 7, 2026, 12:32 PM CET
Clínica Baviera Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 60.11 | 55.99 | 49.65 | 40.68 | 38.9 |
Depreciation & Amortization | 23.9 | 20.88 | 16.98 | 15 | 14.09 |
Other Adjustments | 1.87 | 0.52 | 1.07 | 2.37 | 1.27 |
Changes in Income Taxes Payable | -15.05 | -13.08 | -11.64 | -9.63 | -11.28 |
Changes in Other Operating Activities | 5.66 | -1.81 | 1.76 | 5.03 | 3.79 |
Operating Cash Flow | 76.49 | 62.51 | 57.82 | 53.45 | 46.78 |
Operating Cash Flow Growth | 22.36% | 8.12% | 8.18% | 14.26% | 48.70% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -30.01 | -26.51 | -22.68 | -14.03 | -10.44 |
Sale of Property, Plant & Equipment | - | - | - | - | -0.1 |
Purchases of Investments | -35.95 | -14.16 | -40.53 | -24.52 | -6.46 |
Proceeds from Sale of Investments | 20.34 | 30.57 | 18.73 | 25.45 | - |
Cash Acquisitions | -0.92 | -11.11 | - | - | - |
Proceeds from Business Divestments | 0 | 0.02 | 0.01 | 0.07 | -0 |
Other Investing Activities | 1.52 | 0.3 | 0.15 | - | - |
Investing Cash Flow | -45.02 | -20.9 | -44.32 | -13.03 | -17 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 3 | 7.2 | - | - | 0.08 |
Long-Term Debt Repaid | -2.55 | -2.7 | -2.18 | -6.15 | -5.78 |
Net Long-Term Debt Issued (Repaid) | 0.45 | 4.5 | -2.18 | -6.15 | -5.7 |
Issuance of Common Stock | 2.65 | 1.43 | 0.71 | 0.6 | 0.5 |
Repurchase of Common Stock | -1.52 | -10.24 | -0.71 | -0.62 | -0.49 |
Net Common Stock Issued (Repurchased) | 1.13 | -8.81 | 0.01 | -0.02 | 0.01 |
Common Dividends Paid | -26.41 | -25.89 | -13.57 | -17.19 | -17.35 |
Other Financing Activities | -11.27 | -9.46 | -8.62 | -7.69 | -7.77 |
Financing Cash Flow | -36.1 | -39.66 | -24.36 | -31.04 | -30.8 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.08 | -0.12 | - | - | - |
Net Cash Flow | -4.55 | 1.84 | -10.87 | 9.37 | -1.02 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 46.47 | 36 | 35.13 | 39.41 | 36.33 |
Free Cash Flow Growth | 29.10% | 2.47% | -10.86% | 8.48% | 53.71% |
FCF Margin | 15.40% | 13.71% | 15.62% | 19.86% | 21.03% |
Free Cash Flow Per Share | 2.90 | 2.25 | 2.15 | 2.42 | 2.23 |
Levered Free Cash Flow | 27.01 | 24.19 | 18.21 | 19.74 | 17.86 |
Unlevered Free Cash Flow | 27.74 | 20.39 | 21.41 | 27.12 | 24.47 |